Edition:
United Kingdom

Aeglea Bio Therapeutics Inc (AGLE.OQ)

AGLE.OQ on NASDAQ Stock Exchange Global Market

4.27USD
5:59pm GMT
Change (% chg)

$-0.08 (-1.84%)
Prev Close
$4.35
Open
$4.36
Day's High
$4.39
Day's Low
$4.14
Volume
3,722
Avg. Vol
10,349
52-wk High
$8.14
52-wk Low
$2.81

Select another date:

Mon, Oct 16 2017

BRIEF-Aeglea Biotherapeutics announces clinical collaboration with Merck

* Aeglea Biotherapeutics announces clinical collaboration with Merck to evaluate the combination of Aeglea’S AEB1102 (pegzilarginase) with Merck's Keytruda® (pembrolizumab) for the treatment of small cell lung cancer

BRIEF-Aeglea BioTherapeutics reports Q2 loss per share $0.47‍​

* Aeglea BioTherapeutics provides corporate update and reports second quarter 2017 financial results

Select another date: